- Home
- ITT vs NBIX Comparison
ITT vs NBIX Comparison
Compare ITT & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITT
- NBIX
- Stock Information
- Founded
- ITT 1920
- NBIX 1992
- Country
- ITT United States
- NBIX United States
- Employees
- ITT N/A
- NBIX N/A
- Industry
- ITT Fluid Controls
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ITT Industrials
- NBIX Health Care
- Exchange
- ITT Nasdaq
- NBIX Nasdaq
- Market Cap
- ITT 14.1B
- NBIX 14.4B
- IPO Year
- ITT N/A
- NBIX 1996
- Fundamental
- Price
- ITT $192.38
- NBIX $149.46
- Analyst Decision
- ITT Strong Buy
- NBIX Strong Buy
- Analyst Count
- ITT 10
- NBIX 18
- Target Price
- ITT $201.11
- NBIX $172.06
- AVG Volume (30 Days)
- ITT 482.8K
- NBIX 1.1M
- Earning Date
- ITT 10-29-2025
- NBIX 10-28-2025
- Dividend Yield
- ITT 0.73%
- NBIX N/A
- EPS Growth
- ITT 2.16
- NBIX 12.44
- EPS
- ITT 5.99
- NBIX 4.19
- Revenue
- ITT $3,813,500,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- ITT $7.64
- NBIX $23.68
- Revenue Next Year
- ITT $5.60
- NBIX $18.02
- P/E Ratio
- ITT $31.88
- NBIX $35.79
- Revenue Growth
- ITT 8.01
- NBIX 19.61
- 52 Week Low
- ITT $105.64
- NBIX $84.23
- 52 Week High
- ITT $197.07
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- ITT 64.43
- NBIX 58.02
- Support Level
- ITT $183.25
- NBIX $133.62
- Resistance Level
- ITT $193.83
- NBIX $157.67
- Average True Range (ATR)
- ITT 5.91
- NBIX 5.06
- MACD
- ITT 1.06
- NBIX 0.91
- Stochastic Oscillator
- ITT 81.39
- NBIX 65.74
About ITT ITT Inc.
ITT began its journey as International Telephone & Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.